131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin’s lymphoma

Author:

Hattori Naoya,Gopal Ajay K.,Shields Andrew T.,Fisher Darrell R.,Gooley Ted,Pagel John M.,Press Oliver W.,Rajendran Joseph G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference23 articles.

1. 131I-tositumomab therapy as initial treatment for follicular lymphoma.;Kaminski;N Engl J Med,2005

2. Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I-tositumomab to that of other types of non-Hodgkins lymphoma.;Rajendran;Cancer Biother Radiopharm,2004

3. High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkins lymphoma: adjusting radiation absorbed dose to actual organ volumes.;Rajendran;J Nucl Med,2004

4. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.;Saad;BJU Int,2007

5. Preliminary validation of the opposing view method for quantitative gamma camera imaging.;Eary;Med Phys,1989

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting;Seminars in Nuclear Medicine;2022-03

2. Tositumomab;Adverse Events with Biomedicines;2013-12-10

3. Effects of chemotherapy and radiotherapy on spermatogenesis in humans;Fertility and Sterility;2013-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3